Fingerprint
Dive into the research topics of 'Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
C. M.S. Rocha Lima, N. A. Rizvi, C. Zhang, II E. Herndon, J. Crawford, R. Govindan, G. W. King, M. R. Green
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations